Yitzhaki S, Barnea A, Keysary A, Zahavy E
Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.
J Clin Microbiol. 2004 Apr;42(4):1680-5. doi: 10.1128/JCM.42.4.1680-1685.2004.
Leptospirosis is considered an important reemerging infectious disease worldwide. The standard and most widespread method for the diagnosis of leptospirosis is the microscopic agglutination test (MAT). This test is laborious and time-consuming, and the interpretation of the results is subjective. In the present work we describe an application of flow cytometry (FCM) as a tool for the serological diagnosis of leptospirosis. The analysis is based on the sensitivity of FCM to the size and shape of the bacteria analyzed by measurement of light scatter parameters: forward scatter (FSC) and side scatter (SSC). The addition of positive serum to an infecting leptospiral serovar results in a shift of the light scatter parameter to a different location with higher FSC and SSC values, indicating the formation of leptospiral aggregates. By using immunofluorescent staining, we have shown that the large particles formed are the agglutinated leptospires. Quantification of the agglutination process has been achieved by calculating an agglutination factor (Af), based on changes in the light scatter parameters measured by FCM. Af enables us to determine the specificity of the serological reaction of the patient serum with each leptospiral serovar. In this work, 27 serum samples from 18 leptospirosis patients were tested by both the MAT and the FCM techniques, in which each serum sample was tested against 13 serovars. Twenty-six human serum samples derived from patients with a variety of other defined illnesses were used as negative controls and enabled us to define the Af threshold value as < 9.3 for negative patients, while any value higher than that would be a positive result for leptospirosis. Compared to MAT, the FCM technique was found to be more specific and sensitive, especially in identifying the serogroup in the acute phase of the disease. The whole process was found to be rapid and took less than 1.5 h. Moreover, FCM analysis is objective and can be automated for the handling of large numbers of samples.
钩端螺旋体病被认为是全球一种重要的重新出现的传染病。诊断钩端螺旋体病的标准且最广泛使用的方法是显微镜凝集试验(MAT)。该试验费力且耗时,并且结果的解释具有主观性。在本研究中,我们描述了流式细胞术(FCM)作为钩端螺旋体病血清学诊断工具的一种应用。该分析基于FCM通过测量光散射参数:前向散射(FSC)和侧向散射(SSC)对所分析细菌的大小和形状的敏感性。向感染的钩端螺旋体血清型中加入阳性血清会导致光散射参数转移到具有更高FSC和SSC值的不同位置,表明形成了钩端螺旋体聚集体。通过使用免疫荧光染色,我们已表明形成的大颗粒是凝集的钩端螺旋体。基于FCM测量的光散射参数的变化,通过计算凝集因子(Af)实现了对凝集过程的定量。Af使我们能够确定患者血清与每种钩端螺旋体血清型的血清学反应的特异性。在本研究中,对18例钩端螺旋体病患者的27份血清样本进行了MAT和FCM技术检测,其中每个血清样本针对13个血清型进行检测。来自患有各种其他明确疾病的患者的26份人血清样本用作阴性对照,使我们能够将阴性患者的Af阈值定义为<9.3,而高于该值的任何值对于钩端螺旋体病将是阳性结果。与MAT相比,发现FCM技术更具特异性和敏感性,尤其是在疾病急性期鉴定血清群方面。发现整个过程快速,耗时不到1.5小时。此外,FCM分析是客观的,并且可以自动化以处理大量样本。